Cinacalcet-[d4]

Cinacalcet-[d4], is the labelled analogue of Cinacalcet. Cinacalcet is the first calcimimetic drug approved by the United States Food and Drug Administration for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
Supplier BOC Sciences
Product # BLP-002258
Pricing Inquire
Cas 1228567-29-0
Molecular Weight 361.44
Molecular Formula C22H18D4F3N
Canonical SMILES CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
Feedback